Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesVena cava filter occlusion and venous thromboembolism risk in persistently anticoagulated patients: A prospective, observational cohort study
Chest, 11/03/09
Hajduk B et al. – If therapeutic anticoagulation can be safely begun in patients with IVC filters inserted after venous thromboembolism, further management with clinical surveillance, including ultrasound examination of the IVC filter and graded degrees of anticoagulation therapy if filter clot is detected, has a favorable prognosis. This approach appears valid for current IVC filter patients and can serve as a comparison standard in subsequent clinical trials to optimize clinical management of these patients.
Bogdan Hajduk, 11/06/09
| Permanent IVC filters inevitably produce thrombotic complications. Despite frequent use of retrievable IVC filters, many of them still serve as permanent filters. Our study suggests that flexible clinical approach to VTE patients with IVC filters with ultrasound surveillance and prolonged - occasionally adjusted - anticoagulation prevents excessive rate of DVT in comparison with VTE patients without IVC filters and total filter occlusion. Optimal clinical managament of these patients still needs further investigations |
Today in CV/Thromboembolic...keeping you current
Receive free subspecialty "5-minute updates" via email
The Use of Sildenafil in Persistent Pulmonary Hypertension of the Newborn
American Journal of Perinatology, 10/28/09
Hemodynamic and Gas Exchange Effects of Sildenafil in Patients with COPD and Pulmonary Hypertension
American Journal of Respiratory and Critical Care Medicine, 10/30/09
Pulmonary embolism in pregnancy
The Lancet - Early Online Publication, 11/03/09
Sponsor
Article Search
Sponsor